Screener
Collegium Pharmaceutical, Inc. COLL Deferred Royalty Liability Non Current
Deferred Royalty Liability Non Current at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept coll:DeferredRoyaltyLiabilityNonCurrent.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Term notes payable, net of current portion | 797,824 | 542,112 |
| Convertible senior notes | 238,733 | 238,213 |
| Operating lease liabilities, net of current portion | 3,407 | 4,132 |
| Deferred royalty obligation | 121,357 | 121,563 |
| Deferred revenue, net of current portion | 8,778 | 9,111 |
| Contingent consideration, net of current portion | 22,956 | — |
| Deferred tax liabilities | 40,965 | — |
| Total liabilities | 1,823,881 | 1,355,159 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s deferred royalty liability non current?
- Collegium Pharmaceutical, Inc. (COLL) reported deferred royalty liability non current of $121.36M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s deferred royalty liability non current changed year-over-year?
- Collegium Pharmaceutical, Inc.'s deferred royalty liability non current decreased by 1.0% year-over-year, from $122.63M to $121.36M.
- What does deferred royalty liability non current mean?
- Deferred Royalty Liability Non Current as reported by Collegium Pharmaceutical, Inc. Common Stock.
Ask your AI about Collegium Pharmaceutical, Inc.'s deferred royalty liability non current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude